StonvexLoading…
StonvexStonvexStonvexCore line items from NATH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-30 | Annual 2024 2024-03-31 | Annual 2023 2023-03-26 | Annual 2022 2022-03-27 |
|---|---|---|---|---|
Revenue | $148.18M | $138.61M | $130.78M | $114.88M |
Operating Income | $36.50M | $32.51M | $34.45M | $29.86M |
Net Income | $24.03M | $19.62M | $19.62M | $13.60M |
EPS (Diluted) | $5.87 | $4.80 | $4.80 | $3.30 |
Total Assets | $53.48M | $48.86M | $58.61M | $78.52M |
Total Liabilities | $69.99M | $81.78M | $103.17M | $133.50M |
Cash & Equivalents | $27.80M | $21.03M | $29.86M | $50.06M |
Free Cash Flow OCF − CapEx | $25.02M | $19.69M | $19.21M | $15.84M |
Shares Outstanding | 4.09M | 4.08M | 4.08M | 4.12M |